Literature DB >> 9465708

[Laser in situ keratomileusis (LASIK) for correction of myopia].

M C Knorz1, A Liermann, B Wiesinger, V Seiberth, H Liesenhoff.   

Abstract

BACKGROUND: Laser in situ keratomileusis (LASIK) preserves the corneal epithelium and Bowman's layer, which theoretically minimizes corneal scarring. We, therefore, evaluated the accuracy, stability and safety of LASIK in moderate to high myopia. PATIENTS AND METHODS: Eighty-five eyes (50 patients) treated using the Automatic Corneal Shaper and the Keracor 116 excimer laser were followed up for 1, 6, and 12 months. Spectacle refraction, visual acuity and rate of retreatments were evaluated.
RESULTS: At 12 months, results were as follows: Myopia -5 to -9.9 D (n = 20); 85% within 1 D; regression between one and 12 months < or = 1 D in 90%; uncorrected acuity 20/40 or better in 75%; no loss of two or more lines of visual acuity. Myopia -10 to -14.9 D (n = 33): 73% within 1 D; regression between 1 and 12 months < or = 1 D in 91%; uncorrected acuity 20/40 or better in 79%; 6.1% lost two lines of visual acuity. Myopia -15 to -29 D (n = 32): 31% within 1 D; regression between one and 12 months < or = 1 D in 63%; 6.3% lost two or more lines of visual acuity. Reoperations were performed in two eyes (2.4%) due to epithelial ingrowth or folds of the flap, and in four eyes (4.7%) because of undercorrections or "central islands".
CONCLUSIONS: LASIK is an accurate and stable procedure for correcting myopia of -5 to -15 D. In higher myopia, however, results are not satisfactory.

Entities:  

Mesh:

Year:  1997        PMID: 9465708     DOI: 10.1007/s003470050202

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  1 in total

1.  Cationic liposome-mediated bcl-xl gene transfection into human keratocytes.

Authors:  Lei Liu; Xinyu Li; Xuefei Zhu; Guigang Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.